HomeCROI 2017: Seattle Headlines
CROI 2017: Seattle Headlines
Treatment or watchful waiting for cervical abnormalities in HIV women?
Close monitoring of earlier-stage cervical abnormalities (CIN-2) may be preferable to treatment for many women with HIV, a US study suggests.
The findings, presented at...
Experimental STI prophylaxis in PrEP users
Use of the antibiotic doxycycline as on-demand post-exposure prophylaxis by men who have sex with men (MSM) taking part in the Ipergay HIV pre-exposure...
Prednisone reduces TB-IRIS risk in HIV patients
Patients with HIV had significantly less risk for clinical deterioration due to tuberculosis–related inflammation when given prednisone early in their treatment regimen in a...
Improving HIV service linkage and retention in Mozambique and South Africa
Providing immune cell testing and HIV treatment counseling immediately after a positive HIV test was the first in a series of measures that increased...
A benign circle: Reduced HIV infections in a hard-hit part of Africa
HIV incidence has started to tumble in one of the best-studied groups of people in Africa, the Conference on Retroviruses and Opportunistic Infections (CROI...
Findings from preclinical study evaluating novel class of HIV capsid inhibitors
Gilead Sciences has announced findings from a pre-clinical study evaluating HIV capsid inhibitors (CAIs) for potential use as a long-acting antiretroviral (ARV) treatment. The...
Integrase inhibitor bictegravir matches dolutegravir for first-line tx
Bictegravir, an investigational integrase inhibitor from Gilead Sciences, was highly potent, well tolerated and worked as well as dolutegravir (Tivcay) in a phase 2...
Dual antiretroviral regimen maintains durable HIV suppression after switch
People who switched from standard antiretroviral therapy to a two-drug regimen of dolutegravir (Tivicay) plus rilpivirine (Edurant) were able to maintain an undetectable viral...
Treatment-as-prevention sees substantial transmitted drug resistance but no impact on Tx
A study of the prevalence of transmitted drug resistance in participants in the ANRS 12249 trial of treatment as prevention, which reported its main...
Point-of-care test improves infant HIV diagnosis rate, treatment starts and retention in care
Using a point-of-care test to diagnose HIV in infants significantly improved retention in care, speeded up ART initiation and increased the proportion of infants...